Functions that protect Escherichia coli from DNA-protein crosslinks

DNA Repair
Rachel KrasichKenneth N Kreuzer

Abstract

Pathways for tolerating and repairing DNA-protein crosslinks (DPCs) are poorly defined. We used transposon mutagenesis and candidate gene approaches to identify DPC-hypersensitive Escherichia coli mutants. DPCs were induced by azacytidine (aza-C) treatment in cells overexpressing cytosine methyltransferase; hypersensitivity was verified to depend on methyltransferase expression. We isolated hypersensitive mutants that were uncovered in previous studies (recA, recBC, recG, and uvrD), hypersensitive mutants that apparently activate phage Mu Gam expression, and novel hypersensitive mutants in genes involved in DNA metabolism, cell division, and tRNA modification (dinG, ftsK, xerD, dnaJ, hflC, miaA, mnmE, mnmG, and ssrA). Inactivation of SbcCD, which can cleave DNA at protein-DNA complexes, did not cause hypersensitivity. We previously showed that tmRNA pathway defects cause aza-C hypersensitivity, implying that DPCs block coupled transcription/translation complexes. Here, we show that mutants in tRNA modification functions miaA, mnmE and mnmG cause defects in aza-C-induced tmRNA tagging, explaining their hypersensitivity. In order for tmRNA to access a stalled ribosome, the mRNA must be cleaved or released from RNA polymerase. Mut...Continue Reading

References

Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S BorukhovA Goldfarb
May 1, 1988·Mutation Research·D LalS Friedman
Feb 1, 1988·The Journal of General Virology·C Barron, E G Bade
Aug 25, 1983·Nucleic Acids Research·H M KrauseN P Higgins
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·C J Kenyon, G C Walker
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·M OrlovaS Borukhov
Jan 30, 1995·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D J SherrattR McCulloch
Apr 2, 1993·Science·C P Selby, A Sancar
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·J CourcelleP C Hanawalt
Jun 17, 1998·The Journal of Biological Chemistry·O MuzzinK Severinov
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·J C ConnellyD R Leach
Nov 14, 1998·Cell·M SeigneurB Michel
Aug 17, 1999·The EMBO Journal·E D Roche, R T Sauer
Oct 16, 1999·The EMBO Journal·G D RecchiaD J Sherratt
Feb 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Irina G MinkoR Stephen Lloyd
Aug 2, 2002·Trends in Biochemical Sciences·John C Connelly, David R F Leach
Sep 6, 2002·Biochimica Et Biophysica Acta·Rachel N Fish, Caroline M Kane
Jan 25, 2003·Science·Justin CourcelleCharmain T Courcelle
Apr 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·George Hong, Kenneth N Kreuzer
Jun 27, 2003·DNA Repair·John C ConnellyDavid R F Leach
Sep 13, 2003·The EMBO Journal·Vitaly EpshteinEvgeny Nudler
Mar 31, 2004·Journal of Molecular Biology·Natalia IvanovaMåns Ehrenberg
Feb 23, 2005·Biochemistry·Irina G MinkoR Stephen Lloyd
Mar 30, 2005·Mutation Research·Sharon BarkerDavid Murray
May 25, 2005·Annual Review of Microbiology·Koreaki Ito, Yoshinori Akiyama
Feb 14, 2006·Cell·Alexandra M DeaconescuSeth A Darst
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Joyce T Reardon, Aziz Sancar
May 18, 2007·The Journal of Biological Chemistry·David J BakerTimothy R O'Connor
Sep 7, 2007·Cancer Research·H Kenny KuoKenneth N Kreuzer
Aug 30, 2008·Annual Review of Microbiology·Jeffrey W RobertsJoshua J Filter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.